PurposeIdentify immune-related lncRNA (IRL) signature related to the prognosis and immunotherapeutic efficiency for bladder cancer (BLCA) patients. MethodsA total of 397 samples. which contained RNA-seq and clinical information from The Cancer Genome Atlas (TCGA) database. were used for the following study. https://www.rxkaitori.com/product-category/combi/